Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS)

Annals of the Rheumatic Diseases

Volumn 76, Issue 6, 2017, Pages 942-947

  Kuemmerle Deschner, Jasmin B ^a   Ozen, Seza ^b   Tyrrell, Pascal N ^c   Kone Paut, Isabelle ^d   Goldbach Mansky, Raphaela ^e   Lachmann, Helen ^f   Blank, Norbert ^g   Hoffman, Hal M ^h   Weissbarth Riedel, Elisabeth ⁱ   Hugle, Boris ^j   Kallinich, Tilmann ^k   Gattorno, Marco ^l   Gul, Ahmet ^m   Ter Haar, Nienke ⁿ   Oswald, Marlen ^a   Dedeoglu, Fatma ^o,p   Cantarini, Luca ^q   Benseler, Susanne M ^r  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b HACETTEPE UNIVERSITY   (Turkey)

^c UNIVERSITY OF TORONTO   (Canada)

^d BICÊTRE HOSPITAL   (France)

^e NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^f ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^g UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^j German Centre for Rheumatology in Children and Adolescents   (Germany)

^k CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^l G GASLINI INSTITUTE   (Italy)

^m ISTANBUL UNIVERSITY   (Turkey)

ⁿ UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^o BOSTON CHILDREN S HOSPITAL   (United States)

^p HARVARD MEDICAL SCHOOL   (United States)

^q UNIVERSITY OF SIENA   (Italy)

^r UNIVERSITY OF CALGARY   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CRYOPYRIN; SERUM AMYLOID A; BIOLOGICAL MARKER;

ARTICLE; CINCA SYNDROME; COHORT ANALYSIS; DECISION MAKING; DISEASE SEVERITY; GENE MUTATION; GOLD STANDARD; HUMAN; NLRP3 GENE; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; VALIDATION STUDY; ABNORMALITIES; BLOOD; BONE; CHRONIC DISEASE; COMPLICATION; CONSENSUS DEVELOPMENT; CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES; HEARING LOSS, SENSORINEURAL; MENINGITIS, ASEPTIC; METABOLISM; MUSCULOSKELETAL DISEASES; URTICARIA;

BIOMARKERS; BONE AND BONES; C-REACTIVE PROTEIN; CHRONIC DISEASE; CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES; HEARING LOSS, SENSORINEURAL; HUMANS; MENINGITIS, ASEPTIC; MUSCULOSKELETAL DISEASES; SERUM AMYLOID A PROTEIN; URTICARIA;

EID: 84991687638     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2016-209686     Document Type: Article

References (24)

1. Stojanov S, Kastner DL. Familial autoinflammatory diseases: genetics, pathogenesis and treatment. Curr Opin Rheumatol 2005;17:586-99.
2. Shinkai K, McCalmont TH, Leslie KS. Cryopyrin-associated periodic syndromes and autoinflammation. Clin Exp Dermatol 2008;33:1-9.
3. Hoffman HM, Mueller JL, Broide DH, et al. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 2001;29:301-5.
4. Lachmann HJ, Goodman HJ, Gilbertson JA, et al. Natural history and outcome in systemic AA amyloidosis. N Engl J Med 2007;356:2361-71.
5. Wittkowski H, Kuemmerle-Deschner JB, Austermann J, et al. MRP8 and MRP14, phagocyte-specific danger signals, are sensitive biomarkers of disease activity in cryopyrin-associated periodic syndromes. Ann Rheum Dis 2011;70:2075-81.
6. Cuisset L, Jeru I, Dumont B, et al. Mutations in the autoinflammatory cryopyrin-associated periodic syndrome gene: epidemiological study and lessons from eight years of genetic analysis in France. Ann Rheum Dis 2011;70:495-9.
7. Toplak N, Frenkel J, Ozen S, et al. An international registry on autoinflammatory diseases: the Eurofever experience. Ann Rheum Dis 2012;71:1177-82.
8. Dougados M, Betteridge N, Burmester GR, et al. EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees. Ann Rheum Dis 2004;63:1172-6.
9. ter Haar NM, Oswald M, Jeyaratnam J, et al. Recommendations for the management of autoinflammatory diseases. Ann Rheum Dis 2015;74:1636-44.
10. Harvey N, Holmes CA. Nominal group technique: an effective method for obtaining group consensus. Int J Nurs Pract 2012;18:188-94.
11. Hansen P, Ombler F. A new method for scoring multi-attribute value models using pairwise ranking of alternatives. J Multi Crit Decis Anal 2009;15:87-107.
12. Greenacre MJ. Correspondence analysis in practice. London: Academic Press, 1993.
13. Greenacre MJ. Theory and applications of correspondence analysis. London: Academic Press, 1984.
14. van den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 2013;65:2737-47.
15. Dajani AS, Ayoub E, Bierman FZ, et al. Guidelines for the Diagnosis of Rheumatic Fever Jones Criteria, 1992 Update. JAMA 1992;268:2069-73.
16. AHA Scientific Statement. Diagnostic Guidelines for Kawasaki Disease. Circulation 2001;103:335-6.
17. Yellen ES, Gauvreau K, Takahashi M, et al. Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease. Pediatrics 2010;125:e234-41.
18. Basu N, Watts R, Bajema I, et al. EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis. Ann Rheum Dis 2010;69:1744-50.
19. Federici S, Sormani MP, Ozen S, et al. Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers. Ann Rheum Dis 2015;74:799-805.
20. Ozen S, Pistorio A, Iusan SM, et al. EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Ann Rheum Dis 2010;69:798-806.
21. Giancane G, Ter Haar NM, Wulffraat N, et al. Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever. Ann Rheum Dis 2015;74:635-41.
22. Koné-Paut I, Shahram F, Darce-Bello M, et al. Consensus classification criteria for paediatric Behcet's disease from a prospective observational cohort: PEDBD. Ann Rheum Dis 2016;75:958-64.
23. Aggarwal R, Ringold S, Khanna D, et al. Distinctions between diagnostic and classification criteria? Arthritis Care Res (Hoboken) 2015;67:891-7.
24. Craven A, Robson J, Ponte C, et al. ACR/EULAR-endorsed study to develop Diagnostic and Classification Criteria for Vasculitis (DCVAS). Clin Exp Nephrol 2013;17:619-21.